FTC Set To Take Enforcement Action Against Drugmakers Over Orange Book Patent Listings

 
• By Brenda Sandburg
Orange Book
FTC targets improper patent listings in FDA's Orange Book • Source: Shutterstock

More from Generics

More from Biosimilars & Generics